These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
528 related items for PubMed ID: 18249000
1. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment. Lee JG, Lee CY, Kim DJ, Chung KY, Park IK. Eur J Cardiothorac Surg; 2008 Mar; 33(3):480-4. PubMed ID: 18249000 [Abstract] [Full Text] [Related]
2. Prognostic factors in patients with ipsilateral pulmonary metastasis from non-small cell lung cancer. Nakagawa T, Okumura N, Miyoshi K, Matsuoka T, Kameyama K. Eur J Cardiothorac Surg; 2005 Oct; 28(4):635-9. PubMed ID: 16126398 [Abstract] [Full Text] [Related]
3. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system. Oliaro A, Filosso PL, Cavallo A, Giobbe R, Mossetti C, Lyberis P, Cristofori RC, Ruffini E. Eur J Cardiothorac Surg; 2008 Aug; 34(2):438-43; discussion 443. PubMed ID: 18502660 [Abstract] [Full Text] [Related]
4. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification]. Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H. Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272 [Abstract] [Full Text] [Related]
6. Applicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers. Suzuki M, Yoshida S, Tamura H, Wada H, Moriya Y, Hoshino H, Shibuya K, Yoshino I. Eur J Cardiothorac Surg; 2009 Dec 24; 36(6):1031-6. PubMed ID: 19692261 [Abstract] [Full Text] [Related]
7. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. Pfannschmidt J, Muley T, Bülzebruck H, Hoffmann H, Dienemann H. Lung Cancer; 2007 Mar 24; 55(3):371-7. PubMed ID: 17123661 [Abstract] [Full Text] [Related]
8. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer]. Hosokawa Y, Matsuge S, Murakami Y, Satoh K, Yamazaki S, Kan T, Hatakeyama H. Kyobu Geka; 2000 Oct 24; 53(11):910-4. PubMed ID: 11048440 [Abstract] [Full Text] [Related]
9. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Takeda S, Fukai S, Komatsu H, Nemoto E, Nakamura K, Murakami M, Japanese National Chest Hospital Study Group. Ann Thorac Surg; 2005 Apr 24; 79(4):1142-6. PubMed ID: 15797041 [Abstract] [Full Text] [Related]
10. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification. Christian C, Erica S, Morandi U. Lung Cancer; 2006 Nov 24; 54(2):185-91. PubMed ID: 16996167 [Abstract] [Full Text] [Related]
11. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Casali C, Stefani A, Natali P, Rossi G, Morandi U. Eur J Cardiothorac Surg; 2005 Jul 24; 28(1):33-8. PubMed ID: 15953734 [Abstract] [Full Text] [Related]
12. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment. Getman V, Devyatko E, Dunkler D, Eckersberger F, End A, Klepetko W, Marta G, Mueller MR. Eur J Cardiothorac Surg; 2004 Jun 24; 25(6):1107-13. PubMed ID: 15145017 [Abstract] [Full Text] [Related]
14. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer]. Gao YS, Xing XZ, Shao K, Feng XL, He J. Zhonghua Zhong Liu Za Zhi; 2008 Feb 24; 30(2):134-7. PubMed ID: 18646698 [Abstract] [Full Text] [Related]
15. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease. Iwasaki A, Shirakusa T, Miyoshi T, Hamada T, Enatsu S, Maekawa S, Hiratsuka M. Thorac Cardiovasc Surg; 2006 Feb 24; 54(1):42-6. PubMed ID: 16485188 [Abstract] [Full Text] [Related]
16. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid? Port JL, Korst RJ, Lee PC, Kansler AL, Kerem Y, Altorki NK. Ann Thorac Surg; 2007 Feb 24; 83(2):397-400. PubMed ID: 17257959 [Abstract] [Full Text] [Related]
17. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival. Hung JJ, Wang CY, Huang MH, Huang BS, Hsu WH, Wu YC. J Thorac Cardiovasc Surg; 2007 Sep 24; 134(3):638-43. PubMed ID: 17723811 [Abstract] [Full Text] [Related]
18. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Benoit L, Anusca A, Ortega-Deballon P, Cheynel N, Bernard A, Favre JP. Eur J Surg Oncol; 2006 Jun 24; 32(5):583-7. PubMed ID: 16621424 [Abstract] [Full Text] [Related]
19. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer. Miyoshi K, Moriyama S, Kunitomo T, Nawa S. J Thorac Cardiovasc Surg; 2009 Feb 24; 137(2):429-34. PubMed ID: 19185165 [Abstract] [Full Text] [Related]
20. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Planchard D, Soria JC, Michiels S, Grunenwald D, Validire P, Caliandro R, Girard P, Le Chevalier T. Cancer; 2004 Jan 01; 100(1):28-35. PubMed ID: 14692021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]